Purpose Care | AI Transformation Index
PurposeCare operates in a structurally durable segment of healthcare — physical, licensed, regulated, and physically irreplaceable — which makes it one of ...

Overview
PurposeCare delivers skilled home health and home/community-based services (nursing, therapy, personal care, care coordination) to geriatric and dual-eligible Medicare/Medicaid populations across the Midwest, generating revenue by billing government and commercial payors under fee-for-service and value-based arrangements.
Executive Summary
PurposeCare operates in a structurally durable segment of healthcare — physical, licensed, regulated, and physically irreplaceable — which makes it one of the more AI-resilient service business models in a PE portfolio. The AI opportunity, while bounded by the physical nature of care delivery, is concentrated in exactly the right places: clinical workflow compression, deterioration prediction across complex patient populations, and the enabling of value-based contracts that could structurally reprice the business. The strategic thesis is that AI makes PurposeCare a better, more defensible operator (lower documentation burden, better outcomes, VBC eligibility) without threatening the core revenue base — a favorable combination that justifies continued investment in clinical intelligence infrastructure like Canarai as a competitive differentiator rather than a mere efficiency tool.
Durability
How resilient is this business against AI disruption?
Market Substitutability
Profit Pool Migration
Barrier to Entry
Disintermediation Exposure
Switching Costs
Opportunity
How big a deal is AI for this business?
AI Applicability
Improvement Magnitude
Transformation Upside
Domain Intelligence Amplification
71.6
Ciridae AI Score
Durability Rationale
PurposeCare's durability rests on a structurally sound foundation: the paid outcome is physical clinical care that no AI can replicate, the market is heavily regulated and licensed in ways that create durable entry barriers, and the company owns both the payor contracts and the clinical workforce rather than sitting as a middleman between them. The primary durability risk is not AI substitution of the core service but rather competitive commoditization at the organizational level — at its current scale, PurposeCare has not yet built the switching costs and brand differentiation needed to fend off better-capitalized nationals or tech-enabled platforms that could out-invest it on the AI coordination layer. Regulatory moat and physical delivery irreplaceability are the structural anchors; organizational scale and moat depth are the vulnerability.
Opportunity Rationale
The AI opportunity for PurposeCare is real and concentrated in the workflows surrounding physical care delivery — clinical documentation, deterioration detection, scheduling, and billing — where the magnitude of improvement is genuinely large and the domain intelligence (complex geriatric/dual-eligible patient populations, unstructured clinical data) is rich enough to amplify. The Canarai initiative signals the company already understands where the leverage is. The bigger strategic upside is that AI-enabled risk stratification unlocks value-based contracting at scale — transforming PurposeCare from a fee-for-service visit business into a population health manager that gets paid for outcomes, a fundamentally different and more defensible economic position. The opportunity is bounded by the fact that the majority of revenue hours remain physical and AI-irreducible, so this is not a story of total cost structure transformation, but the addressable AI upside is high-value and strategically differentiated.
Key Risks
The durability view could be wrong if hospital-at-home platforms (backed by major health systems or payers) absorb the complex-patient population and leave PurposeCare with lower-acuity, commoditized non-medical home care — reducing payor contract leverage and intensifying price competition without the clinical differentiation that justifies the roll-up premium.
The opportunity view could be wrong if the Canarai platform and AI clinical intelligence tools remain a feature available to any operator through third-party vendors (e.g., Google Health, Medalogix, Forcura), meaning PurposeCare cannot sustain a differentiated advantage from AI investment and competitors rapidly close any capability gap.
Company Overview
| Headquarters | Jeffersonville, IN (corporate office reported) |
| Products / Services | Skilled nursing, physical/occupational/speech therapy, medical social services, wound and ostomy management, IV/infusion therapy, personal/home care (bathing, ADL assistance, medication reminders, transportation, light housekeeping), comprehensive care coordination and home safety assessments. |
AI & Tech Initiatives
| Name | Description |
|---|---|
| Canarai | Proprietary data platform that ingests 40+ disparate sources (EHRs, clinical notes, caregiver reports, HIEs) and uses generative AI / large language models to analyze unstructured clinical text, surface subtle deterioration signals, provide risk stratification, real-time alerts, and workflow automation to support proactive home health interventions. |
PE / Ownership History
| Event | Details |
|---|---|
Acquired Freedom Home Care March 17, 2026 | Acquisition of Freedom Home Care (Chicagoland / Northern Illinois) to expand PurposeCare's Midwest footprint and concierge home care offerings. No Lorient Capital Partner/Managing Partner named in the public press release. |
Acquired New Era Support Services (reported) July 2025 | Reported acquisition of New Era Support Services (listed in private deal databases). Jordan Broome is the only Lorient individual explicitly named across public materials as associated with PurposeCare transactions. |
Acquired additional Midwestern agencies / equity interests January 2024 | Acquisition/roll-up of three additional Midwestern home-based care agencies (including equity interests in Michiana Home Care and Queen City Skilled Care). No Lorient Capital Partner/Managing Partner named in public announcements. |
Acquired three Midwest home care agencies July 2023 | Acquisition of three Midwest home care agencies (Scott’s Home Healthcare, Attentive Personal Care, The Choice Nursing Care & Home Health) expanding Indiana and Ohio presence. No Lorient Capital Partner/Managing Partner named in public announcements. |
Acquired Home Sweet Home In-Home Care March 21, 2023 | Acquisition of Home Sweet Home In-Home Care (St. Joseph, MI) — expanded Midwest footprint (~400 patients, ~300 caregivers reported for the acquired agency). No Lorient Capital Partner/Managing Partner named in public announcement. |
Initial investment / formation (Lorient Capital-backed) December 2021 | Lorient Capital provided the institutional backing to form PurposeCare and support an initial acquisition strategy to consolidate regional home health and home care agencies. |
Executives
| Name | Background |
|---|---|
Richard (Rich) Keller Chief Executive Officer (CEO) | Former President and VP of Business Development & Strategy at All Metro Health Care; healthcare operator with previous consulting experience; MBA in Marketing. |
Michael Eperesi Chief Financial Officer (CFO) | Former CFO at Guardian Healthcare and advisory roles; background in financial leadership in healthcare and information systems management. |
Rob Barrow Chief Operating Officer (COO) | Joined PurposeCare as COO in 2023; prior operational roles at Lorient Capital portfolio companies and experience running home health/home care operations and operational performance programs. |
Lorient Capital